(Q46907019)

26 December 2017

title

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells (English)

1 reference

26 December 2017

1 reference

1 reference

S Benvenuti

1

1 reference

26 December 2017

I Cellai

2

1 reference

26 December 2017

P Luciani

3

1 reference

26 December 2017

C Deledda

4

1 reference

26 December 2017

S Baglioni

5

1 reference

26 December 2017

C Giuliani

6

1 reference

26 December 2017

R Saccardi

7

1 reference

26 December 2017

B Mazzanti

8

1 reference

26 December 2017

S Dal Pozzo

9

1 reference

26 December 2017

E Mannucci

10

1 reference

26 December 2017

A Peri

11

1 reference

26 December 2017

M Serio

12

1 reference

26 December 2017

publication date

1 October 2007

1 reference

26 December 2017

Journal of Endocrinological Investigation

published in

1 reference

26 December 2017

volume

30

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

RC26-30

1 reference

26 December 2017

https://api.crossref.org/works/10.1007%2FBF03350807

1 reference

Thiazolidinedione use and bone loss in older diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Neuronal differentiation of human mesenchymal stem cells: changes in the expression of the Alzheimer's disease-related gene seladin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Expression of the novel adrenocorticotropin-responsive gene selective Alzheimer's disease indicator-1 in the normal adrenal cortex and in adrenocortical adenomas and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Bone is a target for the antidiabetic compound rosiglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350807

Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17993761

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17993761

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03350807

1 reference

26 December 2017

1 reference

26 December 2017